- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
CA3 Antibody (N-term)Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP7633a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
CA3 Antibody (N-term) - Product info | |
| Application | WB
|
| Primary Accession | P07451 |
| Other Accession | P14141 |
| Reactivity | Human, Mouse |
| Predicted | Rat |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 29557 Da |
CA3 Antibody (N-term) - Additional info | |
| Gene ID 761 | |
| Other Names CA3; Carbonic anhydrase 3; Carbonate dehydratase III; Carbonic anhydrase III | |
| Target/Specificity This CA3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 24~54 amino acids from the N-terminal region of human CA3. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions CA3 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
CA3 Antibody (N-term) - Protein Information | |
| Name CA3 | |
| Function Reversible hydration of carbon dioxide. | |
| Cellular Location Cytoplasm. | |
| Tissue Location Muscle specific. | |
CA3 Antibody (N-term) - Related products
AP7633a: CA3 Antibody (N-term)
AP7633c: CA3 Antibody (Center)
LY11316a: CA3 Over-expression Lysate
BP7633a: CA3 Antibody (N-term) Blocking Peptide
CA3 Antibody (N-term) - Application data
-
Western blot analysis of CA3 antibody (N-term)(Cat.#AP7633a) in HepG2 cell line lysates (35ug/lane). CA3 (arrow) was detected using the purified Pab.
-
Western blot analysis of CA3 antibody (N-term)(Cat.#AP7633a) in mouse kidney tissue lysates (35ug/lane). CA3 (arrow) was detected using the purified Pab.
CA3 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Carbonic anhydrase III (CAIII) is a member of carbonic anhydrase isozymes. These carbonic anhydrases are a class of metalloenzymes that catalyze the reversible hydration of carbon dioxide and are differentially expressed in a number of cell types. The expression of the CA3 gene is strictly tissue specific and present at high levels in skeletal muscle and much lower levels in cardiac and smooth muscle. A proportion of carriers of Duchenne muscle dystrophy have a higher CA3 level than normal.
REFERENCES
Du,A.L., Autoimmunity 42 (3), 209-215 (2009) Dai,H.Y., Mol. Carcinog. 47 (12), 956-963 (2008) Gailly,P., Kidney Int. 74 (1), 52-61 (2008)
